Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-16-000624
Filing Date
2016-07-29
Accepted
2016-07-29 17:26:55
Documents
2
Period of Report
2016-07-29

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER DATED JULY 29, 2016 aurinia6kmcr160729.htm 6-K 5690
2 MATERIAL CHANGE REPORT DATED JULY 29, 2016 exhibit99-1.htm EX-99.1 9133
  Complete submission text file 0001176256-16-000624.txt   15821
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 161795108
SIC: 2834 Pharmaceutical Preparations